Gary N Schwartz

4PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 21, 2023
Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer.

Xu Cao, Kristen E Muller, Mary D Chamberlin

|Jul 13, 2023
Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.

Nicole A Traphagen, Gary N Schwartz, Steven Tau

|Jun 01, 2023
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.

Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar

|Nov 04, 2022
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.

Hope S Rugo, Seock-Ah Im, Fatima Cardoso

Pageof 1

Frequent Collaborators

3 joint publications

Peter A Kaufman

2 joint publications

Fred Kolling

2 joint publications

Eugene Demidenko

2 joint publications

Shannon M Soucy